EphA4 promotes cell proliferation and cell adhesion–mediated drug resistance via the AKT pathway in multiple myeloma
Eph receptor A4 (EphA4), a member of the erythropoietin-producing hepatocellular (Eph) family, has been reported to upregulate in several tumors. However, the role of EphA4 in multiple myeloma has not been clarified yet. In this study, we found that EphA4 promoted proliferation of multiple myeloma c...
Main Authors: | Linlin Ding, Yaodong Shen, Jing Ni, Yiqing Ou, Yangyu Ou, Hong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-03-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317694298 |
Similar Items
-
Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
by: Hatano Manabu, et al.
Published: (2004-11-01) -
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
by: Malgorzata Gajdzis, et al.
Published: (2020-09-01) -
Effects of DTX3L on the cell proliferation, adhesion, and drug resistance of multiple myeloma cells
by: Yaodong Shen, et al.
Published: (2017-06-01) -
Targeting EphA2 in cancer
by: Ta Xiao, et al.
Published: (2020-08-01) -
EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway
by: Zhang R, et al.
Published: (2020-10-01)